AI Article Synopsis
- The impact of the 2019 FDA safety alert about multidrug resistant organisms and the COVID-19 pandemic on pediatric fecal microbiota transplantation (FMT) is not well understood.
- A survey of pediatric gastroenterologists revealed that a significant number altered their FMT practices due to these events, with 47% responding to the FDA alert and 83% to the pandemic, resulting in 61% of programs being stopped.
- Overall, these factors have greatly affected the access and availability of FMT for children.
Article Abstract
Introduction: The impact of the 2019 US Food and Drug Administration safety alert involving transmission of multidrug resistant organisms through fecal microbiota transplantation (FMT), and the COVID-19 pandemic on the use of FMT in children, is unknown.
Methods: A survey of pediatric gastroenterologists performing FMT for Clostridioides difficile infection was conducted.
Results: Of 36 respondents, 17 (47%) and 30 (83%) changed their FMT practices related to the US Food and Drug Administration safety alert and COVID-19 pandemic, respectively, with 22 (61%) of programs halted.
Discussion: The US Food and Drug Administration safety alert and COVID-19 pandemic have substantially influenced the availability and access of FMT for children.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410642 | PMC |
| http://dx.doi.org/10.14309/ajg.0000000000001350 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!